Financials
- Market Capitalization 151.9 M
- Employee 5
- Founded 2021
- CEO Jeffrey A. Meckler
- Website www.indaptusrx.com
- Headquarter Delaware, United States
- FIGI BBG00ZNLVBC8
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-0.13
Relación precio/flujo de caja
—
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 3730 | OTLK Outlook Therapeutics, Inc. - Common Stock | 0.64 USD | 0.00% | +3.23% | -28.09% | +55.15% | 155.81 M USD | ||
| 3740 | TNYA Tenaya Therapeutics, Inc. - Common Stock | 0.69 USD | -1.43% | -1.43% | -5.48% | -38.39% | 154.72 M USD | ||
| 3746 | NRXP NRX Pharmaceuticals, Inc. - Common Stock | 3.55 USD | -1.93% | -0.28% | +16.01% | +99.44% | 153.70 M USD | ||
| 3752 | EQ Equillium, Inc. - Common Stock | 2.39 USD | -2.45% | +4.37% | +4.37% | +43.11% | 151.55 M USD |